Neoadjuvant immunotherapy is safe and efficacious in a phase 2 gastric cancer trial Presented ByDr Filippo Pietrantonio, Fondazione IRCCS Istituto Nazionale dei Tumori, Italy TrialPhase 2, INFINITY ConferenceASCO GI 2023 TypePeer-reviewed article 17 March 2023 08:19